Stockreport

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF Presented new case studies on NX-5948 demonstrating clinical responses in patients with CNS lymphoma and CLL with CNS involvement Announced that it is part of a team [Read more]